Value through Innovation21 April 2014

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

07.09.2011

Boehringer Ingelheim wins Frost & Sullivan Award for Biopharmaceutical Contract Manufacturing

29.08.2011

€1 million awarded to winning projects which aim to prevent atrial fibrillation-related stroke

- For non-UK and non-US media
29.08.2011

Boehringer Ingelheim Broadens its Breast Cancer Trial Programme for Afatinib*

- FOR NON-US MEDIA ONLY
28.08.2011

Pradaxa® (dabigatran etexilate, 150mg bid) shows significant reduction in the risk of stroke over warfarin in patients with atrial fibrillation taking antiplatelet or other concomitant therapies

- For NON-US and NON-UK Healthcare Media Only
26.08.2011

Pradaxa® (dabigatran etexilate) revolutionizes stroke prevention in atrial fibrillation

- For NON-US and NON-UK Healthcare Media Only
25.08.2011

Trajenta® (linagliptin) receives approval for the treatment of type 2 diabetes in Europe

- EX US and UK / Medical Media Only.
10.08.2011

Boehringer Ingelheim licenses ProBioGen's novel GlymaxX® technology

09.08.2011

Positive first half-year 2011 for Boehringer Ingelheim – new growth from innovative medicines /Pradaxa approved in Europe

04.08.2011

Breakthrough therapy PRADAXA® (dabigatran etexilate) first drug in 50 years to gain approval for stroke prevention in atrial fibrillation in EU

- For NON-US and NON-UK Healthcare Media Only
04.08.2011

First novel blood thinner in 50 years for the prevention of strokes caused by common heart rhythm disorder, approved in EU

- For NON-US and NON-UK Consumer Media Only
27.07.2011

Viramune® (nevirapine) prolonged-release once-daily formulation for the treatment of HIV-1 infection receives CHMP recommendation for approval

- For non-US healthcare media
12.07.2011

Stroke prevention: "It is time to act"

06.07.2011

Boehringer Ingelheim and Ashoka’s Changemakers
Launch "Making More Health" Competition

27.06.2011

New data for linagliptin* show clinically meaningful efficacy similar to glimepiride but with fewer cardiovascular events

- EX US and UK. Medical Media Only.
24.06.2011

Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe

- EX US and UK. Medical Media Only.
22.06.2011

Global stroke prevention awareness initiative draws two million votes around the world

- For non-UK and non-US media
21.06.2011

Boehringer Ingelheim and Ashoka announce a global partnership for "Making More Health"

20.06.2011

Boehringer Ingelheim extends "one stop shop" service with new fill and finish capabilities